NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,135 | -41.5% | 411,922 | +8.8% | 0.00% | – |
| Q2 2023 | $183,085 | -26.6% | 378,667 | 0.0% | 0.00% | – |
| Q1 2023 | $249,579 | +59323.6% | 378,667 | 0.0% | 0.00% | – |
| Q4 2022 | $420 | -99.8% | 378,667 | +18.1% | 0.00% | – |
| Q3 2022 | $237,000 | +28.1% | 320,627 | +4.0% | 0.00% | – |
| Q2 2022 | $185,000 | -74.3% | 308,432 | +5.0% | 0.00% | – |
| Q1 2022 | $719,000 | -28.8% | 293,867 | +38.9% | 0.00% | – |
| Q4 2021 | $1,010,000 | +138.2% | 211,500 | +362.1% | 0.00% | – |
| Q3 2021 | $424,000 | +6.0% | 45,766 | +32.8% | 0.00% | – |
| Q2 2021 | $400,000 | – | 34,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 699,731 | $338,320 | 0.28% |
| CVI Holdings, LLC | 483,569 | $233,806 | 0.25% |
| ARMISTICE CAPITAL, LLC | 5,636,000 | $2,725,006 | 0.04% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $30,601 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $77,698 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $14,133 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $8,848 | 0.00% |
| JANE STREET GROUP, LLC | 15,052 | $7,278 | 0.00% |
| UBS Group AG | 2,758 | $1,332 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,028 | 0.00% |